MA
MIG AG
MIG AG is a seed to Series B stage investment firm. It has made 19 investments. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $75.5M (across 7 rounds with reported amounts).
Portfolio
19
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
DM
Dr. Matthias Kromayer
Managing Partner
JK
Jürgen Kosch
Managing Partner
DF
Dr. Fei Tian
Principal
FT
Fei Tian
Principal
FM
Frederick Michna
Principal
MK
Matthias Kromayer
Managing Board Member
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
27 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ncodin | Seed | — | Nov 2025 |
 ASTRA Therapeutics | Seed | — | Jul 2025 |
 Inbolt | Series A | — | Sep 2024 |
 Scirhom | Series A | — | Jul 2024 |
| Inbolt | Series A | — | Jan 2024 |
 Neracare | Series A | — | Jan 2024 |
| AAMSilk GmbH | Series C | — | Apr 2023 |
 Mbiomics | Series A | $12M | Mar 2023 |
 IQM | Series C | $128M | Jul 2022 |
| Inbolt | Seed | $3.2M | Jan 2022 |
 Temedica | Series B | — | Jan 2022 |
 Mimi Hearing Technologies | Series B | $25M | Dec 2021 |
| IIomX | Series B | — | Oct 2021 |
 Kewazo | Series A | — | Sep 2021 |
 Zadient Technologies | Seed | — | Jan 2021 |
 German Bionic | Series A | $20M | Dec 2020 |
| IQM | Growth | $320M | Jan 2020 |
| Temedica | Series B | — | Jan 2020 |
 Konux | Series B | — | Feb 2019 |
| Konux | Unknown | $20M | Apr 2018 |
| Kewazo | Seed | — | Jan 2018 |
 Navvis | Series B | — | Jan 2015 |
| AAMSilk GmbH | Series B | — | Mar 2011 |
| SSuppremol | Series B | — | Jul 2008 |
 Protagen | Unknown | — | Jan 2008 |
Page 1 of 2
Top Co-Investors
MIG Capital AG16 shared
Bayern Kapital3 shared
SOSV3 shared
Salvia3 shared
Gaingels2 shared
Bpifrance2 shared
Exor Ventures2 shared
BNP Paribas2 shared
Tesi2 shared
Wellington Management2 shared
High-Tech Gründerfonds2 shared
Benhamou Global Ventures1 shared
IT-Farm Corporation1 shared
Samsung Catalyst Fund1 shared
Story Ventures1 shared
Realty Corporation1 shared
True Ventures1 shared
Target Global1 shared
Real Ventures1 shared
Last updated: 27 September 2026